Menu Search
Equities

Memscap SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MSBA:DUS

Memscap SA

Actions
  • Price (EUR)4.67
  • Today's Change-0.11 / -2.30%
  • Shares traded--
  • 1 Year change+35.22%
  • Beta0.5336
Data delayed at least 15 minutes, as of Feb 16 2026 07:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Memscap SA is a France-based company engaged in the provision of solutions based on micro-electromechanical systems (MEMS) technology. The Company operates in three market segments-standard products: integrate the design and manufacturing of sensors and multifunctional measurement systems intended for the medical, biomedical, aeronautical and defense industries; custom products: include the design and manufacturing of MEMS components, licensing of intellectual property as well as customer cooperation projects for custom development and production; and dermo-cosmetics division: integrates the operation and management of the group's assets relating to the dermatology and cosmetology sectors, including in particular the Ioma brand.. The Company's products include pressure sensors, pressure transducers, pressure switches, medical accessories, optical attenuators (chips), micro relays and Multi-User MEMS Processes, such as PolyMUMPs, SOIMUMPs, MetalMUMPs, and PiezoMUMPs.

  • Revenue in EUR (TTM)11.53m
  • Net income in EUR743.00k
  • Incorporated1997
  • Employees66.00
  • Location
    Memscap SAParc Activillage des FontainesZI Bernin, Crolles CedexCROLLES 38926FranceFRA
  • Phone+33 476928500
  • Fax+33 476928510
  • Websitehttps://memscap.com/en
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.